| P50 | author | H Honda | Q88632968 |
| | Yoshiyuki Shioyama | Q89460240 |
| P2093 | author name string | Yoshio Matsuo | |
| | Katsumasa Nakamura | |
| | Keiji Matsumoto | |
| | Saiji Ohga | |
| | Tomonari Sasaki | |
| | Kaori Asai | |
| | Makoto Shinoto | |
| | Tadamasa Yoshitake | |
| | Shingo Baba | |
| | Kotaro Terashima | |
| P2860 | cites work | Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer? | Q22306068 |
| | Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review | Q26859511 |
| | Stereotactic body radiation therapy for inoperable early stage lung cancer | Q34010065 |
| | Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging | Q34683147 |
| | Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience | Q36500026 |
| | Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer | Q37909663 |
| | Stereotactic body radiation therapy for stage I non-small-cell lung cancer: a historical overview of clinical studies | Q38084289 |
| | Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship | Q44016399 |
| | Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation | Q44555068 |
| | Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. | Q44936038 |
| | Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography | Q46763864 |
| | Stereotactic radiotherapy for lung and liver tumors using a body cast system: setup accuracy and preliminary clinical outcome. | Q51294636 |
| | Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer. | Q51363298 |
| | Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. | Q53090898 |
| | A clinical evaluation of visual feedback-guided breath-hold reproducibility of tumor location. | Q53325105 |
| | Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination | Q83384245 |
| | Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer | Q84420863 |
| | Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group | Q84524583 |
| | Diagnostic yield of preoperative computed tomography imaging and the importance of a clinical decision for lung cancer surgery | Q85064777 |
| P433 | issue | 1 | |
| P304 | page(s) | 53-58 | |
| P577 | publication date | 2014-05-08 | |
| P1433 | published in | International Journal of Clinical Oncology | Q15758148 |
| P1476 | title | Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience | |
| P478 | volume | 20 | |